Published in Vaccine Weekly, September 12th, 2001
Further evaluation is needed in the field, but the intradermal vaccines appear to offer a cost-effective alternative to intramuscular injection, which may make them ideal for use in developing countries, said S.N. Madhusudana and colleagues at the National Institute for Mental Health and Neuroscience, Karnataka.
"The World Health Organization has advocated two cost-effective intradermal regimens with cell culture...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.